CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms

被引:22
作者
Wassenaar, Catherine A. [1 ]
Zhou, Qian [1 ]
Tyndale, Rachel F. [2 ,3 ]
机构
[1] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Dept Pharmacol & Toxicol, CAMH, Campbell Family Mental Hlth Res Inst, Toronto, ON M5S 1A8, Canada
[3] Univ Toronto, Dept Psychiat, CAMH, Campbell Family Mental Hlth Res Inst, Toronto, ON M5S 1A8, Canada
基金
加拿大创新基金会;
关键词
CYP2A6; end point PCR; gene deletion; hybrid allele; real-time PCR; SNP; NICOTINE METABOLITE RATIO; LUNG-CANCER RISK; IN-VIVO; CYTOCHROME-P450; 2A6; GENE DELETION; TRANSDERMAL NICOTINE; SMOKING-CESSATION; HUMAN LIVER; ALLELE; POLYMORPHISM;
D O I
10.2217/pgs.15.156
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CYP2A6 genotyping is of clinical importance - CYP2A6 gene variants influence nicotine metabolism and are associated with nicotine dependence, cigarettes per day, smoking cessation and the risk for tobacco-associated cancers. CYP2A6 gene variants also influence the metabolism of therapeutic drugs, such as the anticancer agents, tegafur and letrozole. Over the years, CYP2A6 genotyping methods have evolved to incorporate novel gene variants and to circumvent genotyping errors resulting from the high degree of homology between CYP2A6 and neighboring CYP2A genes. Herein, CYP2A6 genotyping strategies are described for commonly genotyped functionally significant alleles including SNPs, small insertions/deletions and more complex structural variants. The methods presented utilize higher throughput SYBR green real-time PCR technology in addition to standard thermocycling.
引用
收藏
页码:147 / 162
页数:16
相关论文
共 54 条
[1]   A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo [J].
Al Koudsi, Nael ;
Ahluwalia, Jasjit S. ;
Lin, Shih-Ku ;
Sellers, Edward M. ;
Tyndale, Rachel F. .
PHARMACOGENOMICS JOURNAL, 2009, 9 (04) :274-282
[2]   Chipping away at the genetics of smoking behavior [J].
Amos, Christopher I. ;
Spitz, Margaret R. ;
Cinciripini, Paul .
NATURE GENETICS, 2010, 42 (05) :366-368
[3]  
Ariyoshi N, 2002, CANCER EPIDEM BIOMAR, V11, P890
[4]   Identification of deletion-junction site of CYP2A6*4B allele lacking entire coding region of CYP2A6 in Japanese [J].
Ariyoshi, N ;
Sekine, H ;
Nakayama, K ;
Saito, K ;
Miyamoto, A ;
Kamataki, T .
PHARMACOGENETICS, 2004, 14 (10) :701-705
[5]   Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C [J].
Ariyoshi, N ;
Takahashi, Y ;
Miyamoto, M ;
Umetsu, Y ;
Daigo, S ;
Tateishi, T ;
Kobayashi, S ;
Mizorogi, Y ;
Loriot, MA ;
Stücker, I ;
Beaune, P ;
Kinoshita, M ;
Kamataki, T .
PHARMACOGENETICS, 2000, 10 (08) :687-693
[6]   CYP2A6 genotype and the metabolism and disposition kinetics of nicotine [J].
Benowitz, Neal L. ;
Swan, Gary E. ;
Jacob, Peyton, III ;
Lessov-Schlaggar, Christina N. ;
Tyndale, Rachel F. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (05) :457-467
[7]   CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people [J].
Binnington, Matthew J. ;
Zhu, Andy Z. X. ;
Renner, Caroline C. ;
Lanier, Anne P. ;
Hatsukami, Dorothy K. ;
Benowitz, Neal L. ;
Tyndale, Rachel F. .
PHARMACOGENETICS AND GENOMICS, 2012, 22 (06) :429-440
[8]   Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity [J].
Dempsey, D ;
Tutka, P ;
Jacob, P ;
Allen, F ;
Schoedel, K ;
Tyndale, RF ;
Benowitz, NL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (01) :64-72
[9]   Clinical Interpretation and Implications of Whole-Genome Sequencing [J].
Dewey, Frederick E. ;
Grove, Megan E. ;
Pan, Cuiping ;
Goldstein, Benjamin A. ;
Bernstein, Jonathan A. ;
Chaib, Hassan ;
Merker, Jason D. ;
Goldfeder, Rachel L. ;
Enns, Gregory M. ;
David, Sean P. ;
Pakdaman, Neda ;
Ormond, Kelly E. ;
Caleshu, Colleen ;
Kingham, Kerry ;
Klein, Teri E. ;
Whirl-Carrillo, Michelle ;
Sakamoto, Kenneth ;
Wheeler, Matthew T. ;
Butte, Atul J. ;
Ford, James M. ;
Boxer, Linda ;
Ioannidis, John P. A. ;
Yeung, Alan C. ;
Altman, Russ B. ;
Assimes, Themistocles L. ;
Snyder, Michael ;
Ashley, Euan A. ;
Quertermous, Thomas .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (10) :1035-1044
[10]   In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function [J].
di Iulio, Julia ;
Fayet, Aurelie ;
Arab-Alameddine, Mona ;
Rotger, Margalida ;
Lubomirov, Rubin ;
Cavassini, Matthias ;
Furrer, Hansjakob ;
Guenthard, Huldrych F. ;
Colombo, Sara ;
Csajka, Chantal ;
Eap, Chin B. ;
Decosterd, Laurent A. ;
Telenti, Amalio .
PHARMACOGENETICS AND GENOMICS, 2009, 19 (04) :300-309